BACKGROUND: The number of terminations of pregnancy for fetal anomalies in Europe (TOPFA) has increased over recent decades. Therefore, it is important that TOPFAs, in addition to all other birth outcomes, are included in the surveillance of congenital anomalies and in studies on possible teratogenic risks of pregnancy exposures. The aim of this study was to evaluate the quality and the accuracy of codes identifying TOPFA cases in hospital databases. METHODS: TOPFA cases recorded in three EUROCAT congenital anomaly registries (Finland, 2010-2014; Funen in Denmark, 2005-2014; and northern Netherlands, 2013-2014) were linked to hospital databases using maternal IDs. RESULTS: A total of 2,114 TOPFA cases over the study period were identified i...
To validate the estimates of Global Burden of Disease (GBD) due to congenital anomaly for Europe by ...
Objective To validate the estimates of Global Burden of Disease (GBD) due to congenital anomaly for ...
International audienceOBJECTIVE: To determine how severe were the conditions leading to termination ...
Background: The number of terminations of pregnancy for fetal anomalies in Europe (TOPFA) has increa...
Objective To determine the prevalence of termination of pregnancy for fetal anomaly (TOPFA) after 23...
Objective Firstly, to assess the completeness of ascertainment in the National Congenital Anomaly Sy...
Electronic health care databases are increasingly being used to investigate the epidemiology of cong...
Objective Firstly, to assess the completeness of ascertainment in the National Congenital Anomaly Sy...
BACKGROUND: Public health organisations use public health indicators to guide health policy. Joint a...
Objective To validate the estimates of Global Burden of Disease (GBD) due to congenital anomaly for ...
BackgroundSurveillance of congenital anomalies is important to identify potential teratogens.Methods...
Objective: To 'map' the current (2004) state of prenatal screening in Europe. Design: (i) Survey of ...
OBJECTIVE: Firstly, to assess the completeness of ascertainment in the National Congenital Anomaly S...
To validate the estimates of Global Burden of Disease (GBD) due to congenital anomaly for Europe by ...
Objective To validate the estimates of Global Burden of Disease (GBD) due to congenital anomaly for ...
International audienceOBJECTIVE: To determine how severe were the conditions leading to termination ...
Background: The number of terminations of pregnancy for fetal anomalies in Europe (TOPFA) has increa...
Objective To determine the prevalence of termination of pregnancy for fetal anomaly (TOPFA) after 23...
Objective Firstly, to assess the completeness of ascertainment in the National Congenital Anomaly Sy...
Electronic health care databases are increasingly being used to investigate the epidemiology of cong...
Objective Firstly, to assess the completeness of ascertainment in the National Congenital Anomaly Sy...
BACKGROUND: Public health organisations use public health indicators to guide health policy. Joint a...
Objective To validate the estimates of Global Burden of Disease (GBD) due to congenital anomaly for ...
BackgroundSurveillance of congenital anomalies is important to identify potential teratogens.Methods...
Objective: To 'map' the current (2004) state of prenatal screening in Europe. Design: (i) Survey of ...
OBJECTIVE: Firstly, to assess the completeness of ascertainment in the National Congenital Anomaly S...
To validate the estimates of Global Burden of Disease (GBD) due to congenital anomaly for Europe by ...
Objective To validate the estimates of Global Burden of Disease (GBD) due to congenital anomaly for ...
International audienceOBJECTIVE: To determine how severe were the conditions leading to termination ...